Table 1. Baseline Characteristics of Patients a,b.
| Variable | RJ Group (n = 20) | Placebo Group (n = 20) | P |
|---|---|---|---|
| Age, y | 50.05 ± 7.31 | 53.75 ± 6.93 | 0.10 |
| Gender c | 0.74 d | ||
| Female | 13 (65) | 12 (60) | |
| Male | 7 (35) | 8 (40) | |
| Weight, kg | 75.45 ± 14.50 | 77.95 ± 11.69 | 0.55 |
| BMI, kg/m 2 | 28.72 ± 4.66 | 29.32 ± 4.19 | 0.67 |
| Duration of diabetes, y | 7.20 ± 3.1 | 7.80 ± 2.8 | 0.87 |
| Fasting blood glucose, mmol/l | 8.62 ± 2.82 | 8.70 ± 2.25 | 0.90 |
| HbA1C, % | 8.14 ± 1.13 | 7.70 ± 0.7 | 0.29 |
| Fasting serum insulin, μU/mL | 11.35 ± 8.26 | 9.49 ± 5.65 | 0.40 |
| Fasting C-peptide, ng/mL | 2.85 ± 1.43 | 3.42 ± 0.97 | 0.15 |
a Abbreviations: BMI, body mass index; RJ, royal jelly.
b Results are expressed as mean ± SD.
c Values are presented as No. (%).
d Chi-square P value.